Skip to main content
. 2024 Jun 6;16(6):e61785. doi: 10.7759/cureus.61785

Table 2. Antimicrobial susceptibility pattern of MDR-AB.

MDR-AB, multi-drug-resistant Acinetobacter baumannii

Antibiotics Susceptible, n (%) Intermediate, n (%) Resistant, n (%) Total
Ceftazidime 34 (41) 0 49 (59) 83
Doxycycline 42 (51) 1 (1) 40 (48) 83
Levofloxacin 51 (61) 3 (4) 29 (35) 83
Meropenem 32 (38) 1 (1) 51 (61) 83
Imipenem 30 (36) 2 (3) 51 (61) 83
Ceftriaxone 21 (25) 1 (1) (74) 83
Cefotaxime 25 (30) 1 (1) 57 (69) 83
Piperacillin tazobactam 46 (56) 1 (1) 36 (43) 83
Cotrimoxazole 36 (43) 1 (1) 46 (56) 83
Cefepime 31 (37) 1 (1) 51 (62) 83
Gentamicin 42 (51) 2 (2) 39 (47) 83
Tobramycin 46 (55) 1 (1) 36 (44) 83
Amikacin 38 (46) 2 (2) 43 (52) 83
Ciprofloxacin 44 (53) 1 (1) 38 (46) 83